U.S. Biopharmaceutical Cmo And Cro Market Size & Outlook
U.S. biopharmaceutical cmo and cro market, 2017-2030 (US$M)
Related Markets
U.S. biopharmaceutical cmo and cro market highlights
- The U.S. biopharmaceutical cmo and cro market generated a revenue of USD 9,223.7 million in 2021 and is expected to reach USD 16,723.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.8% from 2022 to 2030.
- In terms of segment, mammalian was the largest revenue generating source in 2021.
- Mammalian is the most lucrative source segment registering the fastest growth during the forecast period.
Biopharmaceutical cmo and cro market data book summary
| Market revenue in 2021 | USD 9,223.7 million |
| Market revenue in 2030 | USD 16,723.4 million |
| Growth rate | 6.8% (CAGR from 2021 to 2030) |
| Largest segment | Mammalian |
| Fastest growing segment | Mammalian |
| Historical data | 2017 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Mammalian, Non-mammalian |
| Key market players worldwide | Boehringer Ingelheim, Lonza Group Ltd, Innovent Biologics Inc, Rentschler Biopharma SE, JRS Pharma, AGC Inc, Probiogen, FUJIFILM Holdings Corp, Toyobo Co Ltd, Samsung BioLogics, Thermo Fisher Scientific Inc, R1 RCM Inc, WuXi Biologics (Cayman) Inc, AbbVie Inc, Binex, Charles River Laboratories International Inc, Icon PLC, PAREXEL, Labcorp Holdings Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 31.4% of the global biopharmaceutical cmo and cro market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. biopharmaceutical cmo and cro market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,445.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical CMO And CRO Market Scope
Biopharmaceutical CMO And CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. biopharmaceutical cmo and cro market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical cmo and cro market will help companies and investors design strategic landscapes.
Mammalian was the largest segment with a revenue share of 68.18% in 2021. Horizon Databook has segmented the U.S. biopharmaceutical cmo and cro market based on mammalian, non-mammalian covering the revenue growth of each sub-segment from 2017 to 2030.
Increasing adoption and investment in advanced research and manufacturing technologies by CMOs & CROs based in the U.S. is propelling the growth of biopharmaceutical CMO & CRO market in the country. In addition, quality services offered by service providers are driving the biopharma and CMO partnerships in the country.
In addition, expansion of foreign CMOs and CROs into the country is expected to propel the market growth. For instance, in September 2019, Bora Pharmaceuticals received FDA approval for its CMO services and in October 2019, it opened a sales office in Delaware to expand its presence outside Asia and strengthen its market position.
However, lower cost offerings by the companies based in the Asia Pacific region and ongoing U.S.-China trade tensions are expected to restrain the growth of the country over the forecast period.
Reasons to subscribe to U.S. biopharmaceutical cmo and cro market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. biopharmaceutical cmo and cro market databook
-
Our clientele includes a mix of biopharmaceutical cmo and cro market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. biopharmaceutical cmo and cro market , including forecasts for subscribers. This country databook contains high-level insights into U.S. biopharmaceutical cmo and cro market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. biopharmaceutical cmo and cro market size, by source, 2017-2030 (US$M)
U.S. Biopharmaceutical CMO And CRO Market Outlook Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
